The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence

Danysz, Wojciech, Parsons, Chris G.·2003·International Journal of Geriatric Psychiatry
DOI 10.1002/gps.938

Cited by (404)

Items 401–404 of 404

  1. BindingDB Entry 50016452: Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease.
    BindingDB · 2023 · UC San Diego
  2. Engineering human brain microphysiological systems for alzheimer’s disease (AD) and chronic traumatic encephalopathy (CTE) modeling and drug testing: translational promise, limitations, and future directions
    Yeoheung Yun, Satarupa Jena, Hailey Egido-Betancourt, Samuel Uzoechi, Doo Yeon Kim, Jin-Moo Lee, Juliane Nguyen · 2026 · Advanced Drug Delivery Reviews
  3. Restorative Microbiota-Based Therapies for Traumatic Brain Injury: A Systematic Review of Preclinical Studies
    Arati Ankushrao Bhadade, Muskan Talreja, Neha Arya, Arpana Parihar, Amit Gupta, Amit Agrawal · 2026 · Human Brain
  4. α7 nicotinic acetylcholine receptors and memory processes: mechanistic and behavioral studies
    Nick P. van Goethem · 2015 · Research Publications (Maastricht University)